Table 1.
Clinical characteristics of study subjects.
| N | Status | Age (years) |
Cholesterol (mg/dL) |
TG (mg/dL) |
LDL-C (mg/dL) |
HDL-C (mg/dL) |
HDL2-C (mg/dL) |
HDL3-C (mg/dL) |
|
|---|---|---|---|---|---|---|---|---|---|
|
Group 1: Proteomics Study |
6 | CAD | 58 (5) | 230 (93) | 165 (103) |
168 (27) | 42 (12) | 6.4 (3.8) | 36 (10) |
| 6 | CAD + Niacin/Statin |
59 (5) | 142 (29)* | 68 (39)* | 79 (16)* | 56 (16)* | 11 (6.9)* | 45 (11)* | |
| 6 | Healthy Control |
54 (14) | 183 (29)** | 117 (61)** | 121(22)** | 45 (12) | 8.2 (4.3) | 37 (10) | |
|
Group 2: ApoE Validation Study |
18 | CAD | 54 (7) | 227 (33) | 159 (75) | 160 (29) | 41 (9) | 6.6 (3) | 36 (7) |
| 18 | CAD + Niacin/Statin |
55 (7) | 145 (29)* | 78 (41)* | 83 (25)* | 52 (15)* | 10.6 (5.6)* |
41 (10)* | |
Results represent means (SD).
*
P<0.01 by a paired two-tailed Student’s t-test
**
P<0.01 compared to untreated CAD subjects by two-tailed Student’s t-test.
TG, triglycerides; C, cholesterol